Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1978-08-23 and 1978-12-15
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1978
Report date:
1978

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
yes
Remarks:
2 animals per doses per sex
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
tert-butyl peracetate
EC Number:
203-514-5
EC Name:
tert-butyl peracetate
Cas Number:
107-71-1
Molecular formula:
C6H12O3
IUPAC Name:
tert-butyl ethaneperoxoate

Test animals

Species:
rabbit
Strain:
New Zealand White
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: H.A.R.E. Rabbits for Research, Hewitt, New Jersey
- Weight at study initiation: 2304 to 2863 grams
- Housing: individually housed in hanging wire-mesh cages
- Diet: Purina® Rabbit Chow®; ad libitum
- Water: ad libitum
- Acclimation period: 19 days

Administration / exposure

Type of coverage:
occlusive
Vehicle:
not specified
Details on dermal exposure:
TEST SITE
The hair was removed from the back of each rabbit (20-30% of the body surface) with an electric clipper. The skin of one male and one female in each group was abraded with a scalpel blade by making 10 cm long epidermal abrasions every 2 or 3 cm longitudinally over the area of exposure. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. The entire application area was then wrapped with several layers of 75 mm Elastoplast tape. A collar was also applied.

REMOVAL OF TEST SUBSTANCE
- 24-h following application, the bandages and collars were removed and the test sites were wiped clean
Duration of exposure:
24 hours
Doses:
500, 1000, 2000, 4000, 8000 and 16000 mg/kg
No. of animals per sex per dose:
2
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: rabbits were observed for mortality twice daily for a total of 14 days
- Frequency of weighing: immediately prior to test material administration (control weight) and at 7 and 14 days of the observation period
Statistics:
95% confidence limits

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
4 000 mg/kg bw
Based on:
test mat.
95% CL:
2 000 - 8 000
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
5 657 mg/kg bw
Based on:
test mat.
95% CL:
2 828 - 11 314
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
4 757 mg/kg bw
Based on:
test mat.
95% CL:
3 364 - 6 727
Mortality:
Please refer to Table 1 ("Any other information on results incl tables")
Body weight:
other body weight observations
Remarks:
The body weight gain of two females was slightly reduced between day 7 and 14. Two other females lost weight between day 1 and 14. One male showed a very slight lost of weight between day 1 and 7. The body weights of all animals are shown in Table 2 (refer to "Any other information on results incl tables").

Any other information on results incl. tables

Table 1 shows the number of deaths during the observation period.


Table 1: Summary of Mortality































































































Time of observation



Number of Deaths



Dosage Level (mg/kg)



500



1000



2000



4000



8000



16000



M



F



M



F



M



F



M



F



M



F



M



F



Day 1



 



 



 



 



 



 



 



 



2



1



2



1



Day 2



 



 



 



 



 



 



1



 



 



1



 



 



Day 3 -14



 



 



 



 



 



 



 



 



 



 



 



 



Total



0/2



   0/2



0/2



   0/2



0/2



   0/2



1/2



   0/2



2/2



   2/2



2/2



   2/2



M: male


F: female


 


Table 2 shows the body weights obtained during the observation period.


 


Table 2: Summary of body weight measurements



































































































































































Dosage Level (mg/kg)



Animal + Sex



Control Weight (g)



7 Day Weight


(g)



14 Day Weight (g)



500



01 Male



2304



2441



2841



02 Male



2512



2668



2761



01 Female



2525



2731



3088



02 Female



2852



2939



3131



1000



03 Male



2545



2706



2841



04 Male



2429



2442



2530



03 Female



2693



2732



2611



04 Female



2485



2505



2981



2000



05 Male



2310



2421



2733



06 Male



2863



2841



2889



05 Female



2742



2886



2863



06 Female



2358



2205



1971



4000



07 Male



2470



2460



2581



08 Male



2320



died



died



07 Female



2633



2565



2911



08 Female



2569



2211



2423



8000



09 Male



2480



died



died



10 Male



2402



died



died



09 Female



2451



died



died



10 Female



2325



died



died



16000



11 Male



2326



died



died



12 Male



2467



died



died



11 Female



2310



died



died



12 Female



2308



died



died


Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits for the test material (75% active ingredient) were calculated to be as follows: Male Rabbits: 4000 (2000 - 8000) mg/kg bw, Female Rabbits: 5657 (2828 - 11314) mg/kg bw, Combined Male and Female Rabbits: 4757 (3364 - 6727) mg/kg bw. Based on the mixture containing 50% of the active ingredient the dermal LC50 values are expected to be 6000 mg/kg bw (males), 8485.5 mg/kg bw (females) and 7135.5 mg/kg bw (combined male and female).
Executive summary:

An acute dermal toxicity study was performed in 12 male and 12 female New Zealand White rabbits obtained from H.A.R.E. Rabbits for Research, Hewitt, New Jersey.They were individually housed in hanging wire-mesh cages and water and diet were available ad libitum. The rabbits were divided into six groups of two male and two female rabbits each. The test material (75% active ingredient) was applied once only to the backs of the rabbits at the following dosage levels: 500, 1000, 2000, 4000, 8000 and 16000 mg/kg bw. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. The entire application area was then wrapped with several layers of 75 mm Elastoplast tape. The animals were durated for 24 hours. The mortality was checked twice daily for a period of 14 days. The body weight gain were recorded immediately prior to test material (control weight) and on day 7 and 14.


Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits were calculated to be as follows: Male Rabbits: 4000 (2000 - 8000) mg/kg bw, Female Rabbits: 5657 (2828 - 11314) mg/kg bw, Combined Male and Female Rabbits: 4757 (3364 - 6727) mg/kg bw. Based on the mixture containing 50% of the active ingredient the dermal LC50 values are expected to be 6000 mg/kg bw (males), 8485.5 mg/kg bw (females) and 7135.5 mg/kg bw (combined male and female).